Tech Company Financing Transactions

Apic Bio Funding Round

Apic Bio, operating out of Cambridge, secured $40 million from Morningside Group and ALS Investment Fund.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

700 Main St. North
Cambridge, MA 02139
USA

Phone

(857) 302-3757

Website

www.apic-bio.com

Email Address

[email protected]

Overview

Apic Bio is committed to finding cures for patients with genetic diseases. The company is a spin-off from the University of Massachusetts Medical School (UMMS) and is based upon nearly 30 years of gene therapy research by Apic's scientific founders. Apic is developing best-in-class treatment options for rare, devastating neurological and liver diseases.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

John Reilly

        

Chief Financial Officer

Daniel Geffken

        

Chief Technical Officer

Scott Loiler

        

Co-Founder

Robert Brown

        

Co-Founder

Christian Mueller

        

Browse more venture capital transactions:

Prev: 1/7/2019: Belmont Technology venture capital transaction
Next: 1/8/2019: StructionSite venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary